Previously Resources Director at Shelter, the housing charity, Henny draws on 20 years experience in the voluntary sector. She is a Trustee for the Small Charities Coalition, and has been Chair for Aids and Housing (Health and Housing). She has also been a Trustee for Thamesreach and Shelter Trading.
A key figure in haematology, Alejandro holds the Chair of Haematology at The Royal Free Hospital and is President of the European Group for Blood and Marrow Transplantation (EBMT). He has received many prestigious awards for his work and published over 200 papers in peer-reviewed journals (with more than 3,000 citations).
Alejandro has been Chair of AlloStem, the largest EU-funded project for immunotherapy, for four years. His main objectives are to improve the outcomes of stem cell transplants and to find new tools for cell therapy.
Ann is available to discuss issues around recruitment to the bone marrow register, including patient appeals, recruitment levels and policies, donor education and retention of donors on the register.
Previously a Director of MHP Health Mandate, Richard is perhaps best known for his role as Cancer Research UK's Director of Policy and Public Affairs where he oversaw the organisation's policy formulation, external affairs, public campaigning and the tobacco control work that eventually led to the UK smoking ban.
As Communications and Marketing chief, Richard can speak about focused issues such as brand campaigns and register development, as well as give background detail around the organisation’s broader and longer-term goals.
Before joining us, Katie held a number of positions within the public affairs and communications arena, including as Associate Director of a boutique political communications agency, and as European Public Affairs Manager at a FTSE 250 corporation. During this time she managed lobbying and policy campaigns for a range of organisations in the UK and Europe.
At Anthony Nolan, Katy is working to push the boundaries of HLA testing for the charity’s register, by implementing new technologies and achieving high throughput of new donors added to the register. Katy also leads on a collaboration project with NHS Blood & Transplant, making her role key to improving the provision of UK bone marrow donors for blood cancer patients both in the UK and worldwide.
He is also Professor of Immunogenetics at University College London and Chairman of the World Health Organization (WHO) Nomenclature Committee for Factors of the HLA System, and the WHO/IUIS Nomenclature Committee for Killer-cell Immunoglobulin-like Receptors (KIR). He is a former President of the European Federation for Immunogenetics (EFI) and President of the International HLA and Immunogenetics Workshop.
The aim of his research group is to improve the outcome of haematopoietic stem cell transplantation by understanding genetic differences between patients and donors including HLA, KIR and their roles in matching achieved by both bioinformatics and laboratory-based projects. He initiated the IMGT/HLA and IPD-KIR Databases, which are the worldwide resource for HLA and KIR sequences.